Clinical trials / NCT06867107
NCT06867107Phase 2Enrolling by invitation

An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101

Study sponsor: Satellos Bioscience, Inc. · MSLE

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2027-09-30Estimated
Enrollment · participants30Estimated
Source updated2026-09-21Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Treatment emergent adverse events

+ After

Measure: Treatment emergent adverse events Measure: SAT-3247 effect on fat fraction in biceps brachii

Planned enrollment increased by 20 participants

− Before

10 participants (planned)

+ After

30 participants (planned)

Primary completion date changed

− Before

30 Aug 2026

+ After

30 Sep 2027

Check registry source